Repligen Corporation (RGEN)
NASDAQ: RGEN · Real-Time Price · USD
110.12
-4.30 (-3.76%)
Mar 27, 2026, 4:00 PM EDT - Market closed
Repligen Employees
Repligen had 2,000 employees as of December 31, 2025. The number of employees increased by 222 or 12.49% compared to the previous year.
Employees
2,000
Change (1Y)
222
Growth (1Y)
12.49%
Revenue / Employee
$369,128
Profits / Employee
$24,447
Market Cap
6.20B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 2,000 | 222 | 12.49% |
| Dec 31, 2024 | 1,778 | -5 | -0.28% |
| Dec 31, 2023 | 1,783 | -242 | -11.95% |
| Dec 31, 2022 | 2,025 | 173 | 9.34% |
| Dec 31, 2021 | 1,852 | 724 | 64.18% |
| Dec 31, 2020 | 1,128 | 367 | 48.23% |
| Dec 31, 2019 | 761 | 213 | 38.87% |
| Dec 31, 2018 | 548 | 72 | 15.13% |
| Dec 31, 2017 | 476 | 240 | 101.69% |
| Dec 31, 2016 | 236 | 68 | 40.48% |
| Dec 31, 2015 | 168 | 32 | 23.53% |
| Dec 31, 2014 | 136 | 20 | 17.24% |
| Dec 31, 2013 | 116 | -4 | -3.33% |
| Dec 31, 2012 | 120 | -17 | -12.41% |
| Dec 31, 2011 | 137 | 69 | 101.47% |
| May 6, 2010 | 68 | -1 | -1.45% |
| May 31, 2009 | 69 | 13 | 23.21% |
| May 27, 2008 | 56 | 11 | 24.44% |
| Jun 30, 2007 | 45 | 2 | 4.65% |
| Jun 6, 2006 | 43 | 6 | 16.22% |
| Jun 7, 2005 | 37 | -3 | -7.50% |
| Jun 7, 2004 | 40 | -4 | -9.09% |
| May 15, 2003 | 44 | 5 | 12.82% |
| May 15, 2002 | 39 | -1 | -2.50% |
| May 15, 2001 | 40 | 13 | 48.15% |
| May 15, 2000 | 27 | 3 | 12.50% |
| May 15, 1999 | 24 | 0 | - |
| May 29, 1998 | 24 | 4 | 20.00% |
| May 15, 1997 | 20 | 5 | 33.33% |
| Jun 14, 1996 | 15 | -89 | -85.58% |
| Mar 31, 1995 | 104 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| Baxter International | 37,500 |
| Solventum | 20,584 |
| Align Technology | 20,290 |
| Teleflex | 15,500 |
| AptarGroup | 14,000 |
| Avantor | 13,500 |
| Bausch + Lomb | 13,000 |
| Envista Holdings | 12,000 |
RGEN News
- 11 days ago - Repligen Corporation (RGEN) Presents at 2026 KeyBanc Capital Markets Healthcare Virtual Forum Transcript - Seeking Alpha
- 19 days ago - Repligen Corporation (RGEN) Presents at Leerink Global Healthcare Conference 2026 Transcript - Seeking Alpha
- 26 days ago - Baron Health Care Fund Q4 2025 Recent Activity - Seeking Alpha
- 4 weeks ago - Repligen Corporation (RGEN) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Repligen Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Financial Guidance - GlobeNewsWire
- 6 weeks ago - Baron Discovery Fund Q4 2025: Winners, Laggards, Buys & Sells - Seeking Alpha
- 6 weeks ago - Repligen to Report Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 2 months ago - Conestoga Mid Cap Composite Q4 2025 Leaders And Laggards - Seeking Alpha